Today, Sigma Aldrich confirmed that the newly acquired BioReliance business will become part of SAFC, the custom manufacturing and services business unit of Sigma-Aldrich. SAFC President, Gilles Cottier noted that the acquisition would serve to increase the SAFC value proposition and positively leverage the company’s industrial media presence and biological testing capabilities for end user services and solutions.
SAFC Marketing Manager, Nick Johnson, talks about what SAFC is bringing to the “Big Easy” in 2012 and why Informex is a key annual event for SAFC. Please click here to read the full blog.
SAFC’s Verona plant has just been awarded SafeBridge Certification. But what does this mean, and what does the process involve? SafeBridge President and Chief Executive, John Farris, tells all in the following interview with SAFC Live.
Following the introduction of the CHO cell line earlier this year in July, SAFC has just announced the release of a novel CHOZN® GS-/- Zinc Finger Nuclease (ZFN)- modified Chinese Hamster Ovary (CHO) cell line. Designed for use in the production of biopharmaceuticals, the new CHOZN GS-/- cell line is the first commercially available glutamine synthetase (GS) knockout CHO cell line proven to shorten bioproduction times in early development, enabling customers to enhance their speed-to-market and increase cost efficiency. Read more about it on Manufacturing Chemist by clicking here.
Michael James, Global Marketing Manager based at SAFC Lenexa Facility
SAFC Lives presents personnel profiles where we talk to the people and personalities who make SAFC tick, and find out something about their work, what drives them, their aspirations, and what they enjoy doing when they’re not playing a critical role in the ongoing growth of SAFC.
In this edition, we talk with Global Marketing Manager, Michael D. James, who’s based in Lenexa, Kansas and is heavily involved in driving SAFC’s Liquid Growth Strategy.
n the September supplement to BioPharm International, Bretta Erskine, manager of upstream technology and collaborations, EMD Millipore, and SAFC’s very own director of development, Bruce Lehr, discuss the issues of the day relating to cell culture media, including high cell density cell culture operations, animal-component–free media, raw materials origins and auditing, trends in chemically-defined media and fermentation in media production.
You can read the full Q&A here
SAFC and Novozymes Biopharma today announced a 10-year extension of their joint agreement under which SAFC retains exclusive marketing and distribution rights for Novozymes Biopharma’s LONG®R³IGF-I (LONG®R3) growth factor used for industrial cell culture applications.
The highly potent growth factor is manufactured specifically for customers in the cell culture market, to enable them to reduce operational and regulatory complexity and minimize manufacturing risk.
Read the full details of the agreement extension here.
Check out SAFC's latest videos.
ACF (3)
APIs (6)
Bioconjugation (4)
biology (5)
Bioprocessing (15)
Cell biology (10)
CMOs (24)
Continuous Processing – Microreators (5)
Diagnostics (4)
Facilities (10)
Fermentation (5)
Fine Chemicals (7)
HPAPIs (12)
Industry Overview (49)
Media Production (9)
Quality (22)
Regulatory (22)
Solid State Chemistry (8)
Supply Chain (23)
Technologies (14)
Uncategorized (15)
Vaccines (9)
ZFN (7)
WP Cumulus Flash tag cloud by Roy Tanck and Luke Morton requires Flash Player 9 or better.
